Longevity Investors & VC Firms in Boston
14 firms in this list, with a median first check of $1M. 3 of them lead rounds. Generated from verified public data and updated continuously.
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
51 people
K2 HealthVentures
BostonGrowth–Late Stage
22 people
quadraScope Venture Fund
Boston
17 people
Magnetic Ventures
BostonSeed–Series A$1M – $6M
7 people
Polaris Partners
BostonSeed–Growth
14 people
BOLD Longevity
BostonGrowth
10 people
Freemind Investments
BostonSeed
6 people
BEV
BostonSeed–Series A
1 person
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
111 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
5AM Ventures
San FranciscoSeed–Late Stage$100K – $4M
41 people
MVM Life Science Partners
LondonSeed–Growth$20M – $100M
20 people
Taihill Venture
CambridgePre-Seed–Seed
11 people
Iaso Ventures
CambridgeSeed–Series A
12 people
Frequently asked questions
- Who are the top longevity investors & vc firms in boston?
- Top longevity investors & vc firms in boston include MPM BioImpact, K2 HealthVentures, quadraScope Venture Fund, Magnetic Ventures, Polaris Partners, BOLD Longevity, Freemind Investments, BEV — 14 firms in total meet the criteria.
- What is the typical first check among longevity investors & vc firms in boston?
- The median first check among the 14 longevity investors & vc firms in boston tracked here is $1M.
- How many longevity investors & vc firms in boston lead rounds?
- 3 of the 14 longevity investors & vc firms in boston tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (12941)Investors & VC Firms in United States (11979)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.















)
)

)









































